| Lifestyle Intervention Study in Adjuvant Treatment of Early Breast Cancer (NCT00463489) | Ontario Clinical Oncology Group (OCOG) | 2007-08-01 |
| Safety and Efficacy Study of GCSF Therapy to Treat Patients at High Risk for Chemotherapy Induced Severe Neutropenia (NCT00497809) | AviGenics | 2007-08-01 |
| Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ (NCT00438659) | North Central Cancer Treatment Group | 2007-08-01 |
| Chemotherapy Followed by Peripheral Stem Cell Transplantation Plus Biological Therapy in Treating Women With Stage IV Breast Cancer (NCT00020722) | Barbara Ann Karmanos Cancer Institute | 2007-08-01 |
| Test of Digital Breast Tomosynthesis vs. Regular Mammography in Detecting Breast Cancer in Women Undergoing Diagnostic Mammography (NCT00535327) | GE Healthcare | 2007-08-01 |
| A Phase I Study of ABT-888 in Combination With Temozolomide in Cancer Patients (NCT00526617) | AbbVie | 2007-08-01 |
| Phase I Oral mTOR Inhibitor RAD001 in Combo w/ Capecitabine for Metastatic Breast (NCT00473005) | Stanford University | 2007-08-01 |
| Collecting Information From Patients Enrolled in the Breast Specialized Program of Research Excellence (NCT01004562) | University of Alabama at Birmingham | 2007-08-01 |
| Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant (NCT00602446) | Masonic Cancer Center, University of Minnesota | 2007-08-01 |
| Allogeneic Hematopoietic Stem Cell Transplantation With Bevacizumab for Advanced Solid Tumor (NCT00523809) | M.D. Anderson Cancer Center | 2007-08-01 |
| Evaluation of Clinical Significance of Circulating Markers in Breast Cancer Patients Undergoing Herceptin Therapy (NCT00530569) | Alberta Health services | 2007-08-01 |
| Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer (NCT00553410) | ETOP IBCSG Partners Foundation | 2007-08-01 |
| Accelerated Partial Breast Irradiation for Early Breast Cancer (NCT00418210) | Trans Tasman Radiation Oncology Group | 2007-08-01 |
| Family Quality of Life Among Families With a Member Who is a Cancer Patient (NCT00544336) | Vanderbilt-Ingram Cancer Center | 2007-08-01 |
| Sequential Versus Simultaneous Use of Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer (MBC) (NCT00629148) | Fudan University | 2007-08-01 |
| Identifying Circulating Breast Cancer Cells in Women With Metastatic Breast Cancer (NCT00897338) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2007-08-01 |
| Hatha Yoga in Improving Physical Activity, Inflammation, Fatigue, and Distress in Breast Cancer Survivors (NCT00486525) | Ohio State University Comprehensive Cancer Center | 2007-08-01 |
| Test of Digital Breast Tomosynthesis vs. Common Mammography to Detect Breast Cancer for Women Undergoing Breast Biopsy (NCT00535184) | GE Healthcare | 2007-08-01 |
| Irinotecan and Etoposide in Treating Patients With Recurrent, Locally Advanced, or Metastatic Breast Cancer (NCT00693719) | University of Arizona | 2007-08-01 |
| Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast Cancer (NCT00423917) | Alliance for Clinical Trials in Oncology | 2007-08-01 |
| Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cancer Tumors (NCT00511576) | Mirati Therapeutics Inc. | 2007-08-01 |
| Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer (NCT01212887) | Cancer Research UK | 2007-08-01 |
| Ultrasound Based Localization of Lumpectomy Bed in Anatomical Coordinate System (NCT00681304) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2007-08-01 |
| Aromatase Inhibitors in Premenopausal Breast Cancer Patients With Chemotherapy-Induced Ovarian Failure (NCT00555477) | University of Michigan Rogel Cancer Center | 2007-08-01 |
| Lapatinib in Treating Patients With Advanced or Metastatic Breast Cancer That Overexpresses HER2 (NCT00544804) | University of California, San Francisco | 2007-08-01 |
| Capecitabine (Xeloda) and Lapatinib (Tykerb) as First-line Therapy in HER2/Neu-positive Breast Cancer (NCT00496366) | Rutgers, The State University of New Jersey | 2007-07-23 |
| Weight Gain Prevention for Breast Cancer Survivors (NCT00533338) | M.D. Anderson Cancer Center | 2007-07-20 |
| Multihance Versus Magnevist in Breast MRI (NCT00486473) | Bracco Diagnostics, Inc | 2007-07-01 |
| Newer Breast MRI Sequences for the Evaluation of Breast Cancer -FIESTA, Vibrant-DE and IDEAL: Feasibility Evaluation (NCT00579800) | Memorial Sloan Kettering Cancer Center | 2007-07-01 |
| Safety and Efficacy Study Using Rexin-G for Breast Cancer (NCT00505271) | Epeius Biotechnologies | 2007-07-01 |
| BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors (NCT00526149) | European Organisation for Research and Treatment of Cancer - EORTC | 2007-07-01 |
| Investigating the Biological Effects of the Addition of Zoledronic Acid to Pre-operative Chemotherapy in Breast Cancer (NCT00525759) | Sheffield Teaching Hospitals NHS Foundation Trust | 2007-07-01 |
| Paclitaxel Followed by FEC Versus Paclitaxel and RAD001 Followed by FEC In Women With Breast Cancer (NCT00499603) | M.D. Anderson Cancer Center | 2007-07-01 |
| Evaluation of Maxy-G34 in Breast Cancer Patients Treated With TAC (Docetaxel, Adriamycin, Cyclophosphamide) Chemotherapy (NCT00501332) | Maxygen Holdings Ltd. | 2007-07-01 |
| Erlotinib Plus Chemotherapy for Treatment of Triple Negative Breast Cancer (NCT00491816) | University of Kansas Medical Center | 2007-07-01 |
| Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients (NCT00526045) | Novartis Pharmaceuticals | 2007-07-01 |
| Phase II Trial of Neoadjuvant Metronomic Chemotherapy in Triple-Negative Breast Cancer (NCT00542191) | Leo W. Jenkins Cancer Center | 2007-07-01 |
| Helping Women Stay Up-To-Date With Cancer Screening By Using a Prevention Care Manager or Usual Care (NCT00477646) | Dartmouth-Hitchcock Medical Center | 2007-07-01 |
| Retrospective Observational Trial on Reasons for Withdraw of Adjuvant Tamoxifen in Breast Cancer Patients (NCT00727883) | AstraZeneca | 2007-07-01 |
| Factors Affecting Decisions About Breast Reconstruction After Mastectomy in Black and Latina Women (NCT00519974) | Memorial Sloan Kettering Cancer Center | 2007-07-01 |
| PhII Neo-Adjuvant Letrozole & Lapatinib in Pts w/HER2+ & Hormone Receptor+ Operable Breast CA SPORE (NCT00499681) | Vanderbilt-Ingram Cancer Center | 2007-07-01 |
| Open Label Trial of INCB07839 to Determine Effect and Safety of INCB007839 Plus Trastuzumab in HER2 Positive Metastatic Breast Cancer (NCT00864175) | Incyte Corporation | 2007-07-01 |
| ZK219477 (Sagopilone) in Patients With Breast Cancer and Brain Metastases (NCT00496379) | Nancy Lin, MD | 2007-07-01 |
| Genexol-PM Versus Paclitaxel in Anthracycline-pretreated Metastatic Breast Cancer Patients (NCT01169870) | National Cancer Center, Korea | 2007-07-01 |
| Androgen Therapy for Breast Cancer Patients With Aromatase Inhibitor Induced Side-Effects (NCT00497458) | Havah Therapeutics Pty Ltd | 2007-07-01 |
| Effects of Physical Activity and Dietary Change in Minority Breast Cancer Survivors (NCT00811824) | Columbia University | 2007-07-01 |
| Trastuzumab (Herceptin), Bevacizumab, and Docetaxel (Taxotere) Trial in Stage IV Metastatic Breast Cancer (MBC) Patients (NCT00428922) | Bhuvaneswari Ramaswamy | 2007-06-14 |
| NOV-002, Doxorubicin, Cyclophosphamide, and Docetaxel in Women With Newly Diagnosed Stage II or IIIC Breast Cancer (NCT00499122) | University of Miami | 2007-06-04 |
| A Study to Evaluate the Safety, Tolerability, and Activity of Lonafarnib and Docetaxel (Study P04467AM1)(TERMINATED) (NCT00539968) | Merck Sharp & Dohme LLC | 2007-06-01 |
| 1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) Therapy (NCT00493636) | Accelerated Community Oncology Research Network | 2007-06-01 |
| Physical Activity or Usual Care in Preventing Weight Gain in Women With Stage I or Stage II Breast Cancer Undergoing Chemotherapy (NCT00509626) | Fox Chase Cancer Center | 2007-06-01 |
| Lapatinib and Vinorelbine in Treating Women With HER2-Overexpressing Locally Advanced or Metastatic Breast Cancer (NCT00513058) | UNICANCER | 2007-06-01 |
| Testing Digital Breast Tomosynthesis vs. Regular Mammogram in Detecting Breast Cancer in Women Having Screening Mammogram (NCT00535678) | GE Healthcare | 2007-06-01 |
| Study of Cancer Peptides Vaccine Plus GM-CSF as Adjuvant Treatment for High Risk (TXN2-3M0) or Metastatic Breast Cancer With No Evidence of Disease (NCT00674791) | Duke University | 2007-06-01 |
| Phase II Trial of Neoadjuvant[FEC100]/Cisplatin-Docetaxel ± Trastuzumab in Women With Over Expressed or Amplified Her2/Neu With Locally Advanced Breast Cancer (NCT00535509) | King Faisal Specialist Hospital & Research Center | 2007-06-01 |
| Evaluating the Effect of Candesartan vs Placebo in Prevention of Trastuzumab-associated Cardiotoxicity (NCT00459771) | The Netherlands Cancer Institute | 2007-06-01 |
| Purged Circulating Tumor Cells (CTCs) From Metastatic Breast Cancer (NCT00429182) | M.D. Anderson Cancer Center | 2007-06-01 |
| Partial Breast Radiation Therapy in Treating Women Undergoing Breast-Conserving Therapy for Early Stage Breast Cancer (NCT00527293) | Case Comprehensive Cancer Center | 2007-06-01 |
| Dehydroepiandrosterone (DHEA) and Letrozole in Treating Patients With Metastatic Breast Cancer (NCT00516542) | OHSU Knight Cancer Institute | 2007-06-01 |
| Implant-based Breast Reconstruction and Mastectomy With Fat Grafting After Breast Conserving Surgery and Radiotherapy (NCT06119633) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2007-06-01 |
| A Safety and Immunology Study of a Modified Vaccinia Vaccine for HER-2(+) Metastatic Breast Cancer (NCT00485277) | Bavarian Nordic | 2007-06-01 |
| Abraxane, Avastin, and Gemcitabine as First-Line Therapy for Patients With Metastatic Breast Cancer (NCT00503906) | University of Miami | 2007-06-01 |
| Short-term Presurgical Study to Assess Molecular Predictors of Lapatinib's Effects in Primary Breast Cancer (NCT00299286) | Institute of Cancer Research, United Kingdom | 2007-06-01 |
| Assessment of Quality of Life, Bone Density and Safety in Postmenopausal Breast Cancer Patients With Letrozole Therapy (NCT00913016) | Korean Breast Cancer Study Group | 2007-06-01 |
| Genetics of Women With Lobular Carcinoma in Situ of the Breast (NCT00536718) | National Cancer Research Network | 2007-06-01 |
| Pazopanib in Treating Patients With Recurrent or Metastatic Breast Cancer (NCT00509587) | National Cancer Institute (NCI) | 2007-06-01 |
| Platinum for Triple-Negative Metastatic Breast Cancer and Evaluation of p63/p73 as a Biomarker of Response (NCT00483223) | Massachusetts General Hospital | 2007-06-01 |
| Adj TC + Herceptin Early Stage Breast Cancer (NCT00493649) | US Oncology Research | 2007-06-01 |
| Use of Dermal Matrix in Breast Reconstruction (NCT00692692) | Vanderbilt University | 2007-06-01 |
| Breast and Cervical Cancer Educational Intervention for Latinas in Western New York (NCT01760850) | Roswell Park Cancer Institute | 2007-06-01 |
| Phase 2b Study of Taxol Plus Sorafenib or Placebo in Patients With Advanced Breast Cancer (NCT00499525) | Northwestern University | 2007-06-01 |
| Chemotherapy-Induced Changes to Cognition and DNA in Breast Cancer Survivors (NCT00496613) | Memorial Sloan Kettering Cancer Center | 2007-06-01 |
| Quality Of Life While Receiving Faslodex (NCT00643513) | AstraZeneca | 2007-06-01 |
| TAC Versus TC for Adjuvant Breast Cancer (NCT00493870) | US Oncology Research | 2007-05-29 |
| Association of Dihydropyrimidine Dehydrogenase (DPYD) Variants With Toxicity Related to Capecitabine (NCT00478686) | M.D. Anderson Cancer Center | 2007-05-23 |
| Lapatinib in Combination With Trastuzumab in Patients With HER2-Positive, Metastatic Breast Cancer (NCT00470704) | Nancy Lin, MD | 2007-05-14 |
| Radiation Therapy in Women With Low Risk Early-Stage Breast Cancer Who Have Undergone Breast Conservation Surgery (NCT00814567) | Institute of Cancer Research, United Kingdom | 2007-05-03 |
| Yoga Study in Breast Cancer Patients (NCT00476203) | Fred Hutchinson Cancer Center | 2007-05-01 |
| Preserving Function in Breast Cancer Patients (NCT00429286) | Dartmouth-Hitchcock Medical Center | 2007-05-01 |
| A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen (NCT00623831) | Ludwig Institute for Cancer Research | 2007-05-01 |
| Tamoxifen Resistance in Women With Stage I, Stage II, Stage IIIA, or Stage IIIB Breast Cancer (NCT00899197) | Wake Forest University Health Sciences | 2007-05-01 |
| Phase II Study With Abraxane, Bevacizumab and Carboplatin in Triple Negative Metastatic Breast Cancer (NCT00479674) | Duke University | 2007-05-01 |
| Blood Levels of Tumor Cells in Predicting Response in Patients Receiving First-Line Chemotherapy for Stage IV Breast Cancer (NCT00898014) | Institut Curie | 2007-05-01 |
| The Biology of Claudin 3 in Primary Human Mammary Epithelial Cell Culture (NCT00481585) | Hackensack Meridian Health | 2007-05-01 |
| A Biological Sample Collection Protocol of Women With and Without Breast Cancer (NCT00472589) | Hoosier Cancer Research Network | 2007-05-01 |
| Adjuvant Doxorubicin/Cyclophosphamide and Paclitaxel Plus Sorafenib Breast Cancer (NCT00544167) | SCRI Development Innovations, LLC | 2007-05-01 |
| Pegylated Liposomal Doxorubicin and Docetaxel in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery (NCT00524459) | Roswell Park Cancer Institute | 2007-05-01 |
| Patient Navigator Project (NCT00375024) | H. Lee Moffitt Cancer Center and Research Institute | 2007-05-01 |
| Sonographic Visibility of Breast Biopsy Marker Clips Up to 4 Weeks After Placement (NCT00548392) | Fred Hutchinson Cancer Center | 2007-05-01 |
| A Phase II Safety and Tolerability Study of Bevacizumab When Added to Single-agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain (NCT00476827) | Duke University | 2007-05-01 |
| Breast Cancer Trials Education Program (NCT02808598) | University of California, San Diego | 2007-05-01 |
| APOLLO(Aromatase Inhibitor Patient cOmpLiance Program With qoL Questionaire) (NCT00523315) | AstraZeneca | 2007-05-01 |
| Prevention of Persistent Alopecia Following Docetaxel by Means of Scalp Cooling (NCT00515762) | Hospital San Carlos, Madrid | 2007-05-01 |
| Computed Radiography (CR) Data Collection for Mammography Computer Aided Detection (CAD) (NCT00610831) | University of California, Irvine | 2007-05-01 |
| Effects of Chemotherapy on the Brain in Women With Newly Diagnosed Early-Stage Breast Cancer (NCT00755313) | University of California, San Francisco | 2007-05-01 |
| Pain in Cancer Survivors (NCT00581724) | Memorial Sloan Kettering Cancer Center | 2007-05-01 |
| Bevacizumab and Abraxane as Second-line Therapy in Triple Negative Metastatic Breast Cancer (NCT00472693) | Abramson Cancer Center at Penn Medicine | 2007-05-01 |
| Therapy With Bevacizumab (BEV), Epirubicin, and Cyclophosphamide Followed by Docetaxel Plus Trastuzumab and BEV Given as Neoadjuvant or Adjuvant Therapy for Women With Locally Advanced HER2 Positive Invasive Breast Cancer (NCT00464646) | NSABP Foundation Inc | 2007-05-01 |
| Observational Usage Study of Faslodex in Patients Suffering From Initial Breast Cancer in France (NCT00681369) | AstraZeneca | 2007-05-01 |
| Anastrozole and Letrozole (NCT00762294) | UConn Health | 2007-05-01 |